BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33894192)

  • 1. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study.
    Westeneng HJ; van Veenhuijzen K; van der Spek RA; Peters S; Visser AE; van Rheenen W; Veldink JH; van den Berg LH
    Lancet Neurol; 2021 May; 20(5):373-384. PubMed ID: 33894192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis.
    Huisman MH; Seelen M; van Doormaal PT; de Jong SW; de Vries JH; van der Kooi AJ; de Visser M; Schelhaas HJ; van den Berg LH; Veldink JH
    JAMA Neurol; 2015 Oct; 72(10):1155-62. PubMed ID: 26280944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes.
    Julian TH; Glascow N; Barry ADF; Moll T; Harvey C; Klimentidis YC; Newell M; Zhang S; Snyder MP; Cooper-Knock J; Shaw PJ
    EBioMedicine; 2021 Jun; 68():103397. PubMed ID: 34051439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.
    Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF;
    Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers.
    Dorst J; Weydt P; Brenner D; Witzel S; Kandler K; Huss A; Herrmann C; Wiesenfarth M; Knehr A; Günther K; Müller K; Weishaupt JH; Prudlo J; Forsberg K; Andersen PM; Rosenbohm A; Schuster J; Roselli F; Dupuis L; Mayer B; Tumani H; Kassubek J; Ludolph AC
    EBioMedicine; 2023 Apr; 90():104521. PubMed ID: 36917918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological Characterization of C9ORF72-Associated Amyotrophic Lateral Sclerosis: A Retrospective Study.
    Pegat A; Bouhour F; Mouzat K; Vial C; Pegat B; Leblanc P; Broussolle E; Millecamps S; Lumbroso S; Bernard E
    Eur Neurol; 2019; 82(4-6):106-112. PubMed ID: 32018264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.
    Bertrand A; Wen J; Rinaldi D; Houot M; Sayah S; Camuzat A; Fournier C; Fontanella S; Routier A; Couratier P; Pasquier F; Habert MO; Hannequin D; Martinaud O; Caroppo P; Levy R; Dubois B; Brice A; Durrleman S; Colliot O; Le Ber I;
    JAMA Neurol; 2018 Feb; 75(2):236-245. PubMed ID: 29197216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.
    O'Brien M; Burke T; Heverin M; Vajda A; McLaughlin R; Gibbons J; Byrne S; Pinto-Grau M; Elamin M; Pender N; Hardiman O
    JAMA Neurol; 2017 Dec; 74(12):1425-1430. PubMed ID: 29049464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
    Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurite density is reduced in the presymptomatic phase of
    Wen J; Zhang H; Alexander DC; Durrleman S; Routier A; Rinaldi D; Houot M; Couratier P; Hannequin D; Pasquier F; Zhang J; Colliot O; Le Ber I; Bertrand A;
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):387-394. PubMed ID: 30355607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies.
    Davidson YS; Robinson AC; Rollinson S; Pickering-Brown S; Xiao S; Robertson J; Mann DMA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):102-111. PubMed ID: 28766957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions.
    Shoukry RS; Waugh R; Bartlett D; Raitcheva D; Floeter MK
    Neuroimage Clin; 2020; 28():102354. PubMed ID: 32769055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in verbal fluency in presymptomatic
    Lulé DE; Müller HP; Finsel J; Weydt P; Knehr A; Winroth I; Andersen P; Weishaupt J; Uttner I; Kassubek J; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1195-1200. PubMed ID: 32855285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression in
    Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
    Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical activity and the association with sporadic ALS.
    Veldink JH; Kalmijn S; Groeneveld GJ; Titulaer MJ; Wokke JH; van den Berg LH
    Neurology; 2005 Jan; 64(2):241-5. PubMed ID: 15668420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.
    Scialò C; Novi G; Bandettini di Poggio M; Canosa A; Sormani MP; Mandich P; Origone P; Truffelli R; Mancardi GL; Caponnetto C
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):535-542. PubMed ID: 27399231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting disease progression in C9ORF72 ALS patients.
    Mandrioli J; Zucchi E; Martinelli I; Van der Most L; Gianferrari G; Moglia C; Manera U; Solero L; Vasta R; Canosa A; Grassano M; Brunetti M; Mazzini L; De Marchi F; Simonini C; Fini N; Tupler R; Vinceti M; Chiò A; Calvo A
    J Neurol; 2023 Feb; 270(2):877-890. PubMed ID: 36280624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.